Stentys Appoints Medical Device Executive To Its Board Of Directors
STENTYS (FR0010949404 – STNT), a medical technology company commercializing the world’s first and only Self-Apposing® stent to treat acute myocardial infarction (AMI), today announced that Dianne Blanco has been appointed as a Director to replace the representative from Omnes Capital venture capital fund.
Help employers find you! Check out all the jobs and post your resume.